The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA971 Remdesivir and tixagevimab plus cilgavimab for treating COVID-19.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation closes at 5pm on Thursday 30th May 2024. Take part by visiting the consultations page.